COL6A3 and colorectal carcinoma: Particularly noteworthy is the strong stromal expression of COL4A1, COL6A3, and COL1A1 in CRC, which multiple studies have associated with adverse clinical outcomes, suggesting their potential utility as stromal-derived prognostic markers [47].